4-n-butylresorcinol has been researched along with beta-thujaplicin in 3 studies
| Studies (4-n-butylresorcinol) | Trials (4-n-butylresorcinol) | Recent Studies (post-2010) (4-n-butylresorcinol) | Studies (beta-thujaplicin) | Trials (beta-thujaplicin) | Recent Studies (post-2010) (beta-thujaplicin) |
|---|---|---|---|---|---|
| 23 | 7 | 19 | 205 | 3 | 99 |
| Protein | Taxonomy | 4-n-butylresorcinol (IC50) | beta-thujaplicin (IC50) |
|---|---|---|---|
| E3 ubiquitin-protein ligase Mdm2 isoform a | Homo sapiens (human) | 3.58 | |
| protein Mdm4 isoform 1 | Homo sapiens (human) | 3.58 | |
| Polyphenol oxidase 2 | Agaricus bisporus | 0.09 | |
| Carboxypeptidase A1 | Bos taurus (cattle) | 2.76 | |
| Tyrosinase | Homo sapiens (human) | 8.98 | |
| Breast cancer type 1 susceptibility protein | Homo sapiens (human) | 3.89 | |
| BRCA1-associated RING domain protein 1 | Homo sapiens (human) | 3.89 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, SH; Manickam, M; Namasivayam, V; Pillaiyar, T | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Choi, YG; Kim, DS; Kim, MK; Kim, SY; Kwon, SB; Na, JI; Park, KC; Park, SH; Youn, SW | 1 |
1 review(s) available for 4-n-butylresorcinol and beta-thujaplicin
| Article | Year |
|---|---|
Inhibitors of Melanogenesis: An Updated Review.
Topics: alpha-MSH; Biphenyl Compounds; Crystallization; Enzyme Inhibitors; Humans; Melanins; Monophenol Monooxygenase; Peptidomimetics; Radiation, Ionizing; Resveratrol; Signal Transduction; Skin | 2018 |
2 other study(ies) available for 4-n-butylresorcinol and beta-thujaplicin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.
Topics: Animals; Blotting, Western; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Drug Synergism; Humans; Hypopigmentation; Melanins; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Monoterpenes; Resorcinols; Signal Transduction; Skin Pigmentation; Tropolone | 2005 |